Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis: A randomized, phase III, double‐blind, placebo‐controlled study

Psoriasis, a chronic inflammatory skin disease, negatively impacts patients’ quality of life (QoL). This randomized, phase III, double‐blind, placebo‐controlled, multicenter study evaluated the efficacy and safety of brodalumab, a human anti‐interleukin‐17 receptor A monoclonal antibody, in Korean p...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Seong Jun, Shin, Bong Seok, Lee, Joo‐Heung, Jeong, Haeyoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246806/
https://www.ncbi.nlm.nih.gov/pubmed/33373480
http://dx.doi.org/10.1111/1346-8138.15733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246806/
https://www.ncbi.nlm.nih.gov/pubmed/33373480
http://dx.doi.org/10.1111/1346-8138.15733

Ejemplares similares